Objectives: Plasmids play a major role in the dissemination of antibiotic resistance, and several studies have shown the association between specific resistance mechanisms and certain plasmid types and/or Escherichia coli lineages. This study describes the distribution of plasmids, replicon types, sequence types (STs) and ST complexes (STCs) of E. coli devoid of phenotypic resistance to 24 antibiotics.
Introduction
Bacteria may acquire antibiotic resistance either through de novo mutations or via horizontal gene transfer (HGT).
1,2 During recent years, several methods have been used to study HGT, but mainly in isolates with antibiotic resistance. In Enterobacteriaceae, plasmid-mediated resistance is of major importance. 2 Using multilocus sequence typing (MLST) and the sequence data of several housekeeping genes, the clonal relatedness of isolates can be studied. This method divides a species into sequence types (STs) and ST complexes (STCs). 3, 4 The most frequently reported STs associated with antibiotic resistance are ST69 with co-trimoxazole resistance, 5 ST393 with multiresistance, 6 and ST131 with extended-spectrum b-lactam resistance due to the bla CTX-M-15 gene 7 and fluoroquinolone resistance. 8 The epidemiology of resistance due to HGT is complex and the relationship between different plasmids remains to be defined. A PCR-based replicon typing (PBRT) scheme, first introduced by Carattoli et al., 9 is now widely used for this purpose. The method identifies 18 of the 27 major plasmid incompatibility groups (Inc) found in Enterobacteriaceae. 10 The most widespread Inc family, IncF (FIA, FIB, FIC and FII), is a heterogeneous group of plasmids commonly found in collections of Escherichia coli. 1, 10, 11 These plasmids seem to play a major role in the dissemination of antibiotic resistance in Enterobacteriaceae, and some have been associated with specific genes conferring resistance to b-lactams, quinolones and aminoglycosides. 12, 13 Despite the importance of plasmids in the dissemination of antibiotic resistance, very few studies have addressed the presence of plasmids and replicon types in isolates devoid of resistance [wild-type (WT)]. Datta and Hughes 14 studied isolates collected in the 'pre-antibiotic era' (before 1954), and revealed the same Inc groups that are found in multiresistant isolates of today. Knowledge of the presence and distribution of plasmids in WT E. coli of the present day remains limited. In this study, we looked for STs, plasmid content and replicon types known to be associated with antibiotic resistance in a collection of WT E. coli, devoid of phenotypically detectable resistance to 24 antibiotics.
Materials and methods

Bacterial strains
One hundred and twenty-seven E. coli isolates were obtained from the two previously described ECO . SENS studies on uncomplicated urinary tract infections (UTIs) in Europe. 15, 16 In brief, these isolates were collected from uncomplicated UTIs referred by general practitioners in four European countries (Greece, Portugal, Sweden and the UK). Seventy-eight isolates were from ECO . SENS 1 (collected in 1999-2000) and 49 were from ECO . SENS 2 (collected in 2007-08). The isolates were chosen because they had previously been tested fully susceptible to 12 antibiotics [ampicillin, co-amoxiclav, mecillinam, cefadroxil, trimethoprim, sulfamethoxazole (alone and in combination with trimethoprim), ciprofloxacin, nalidixic acid, nitrofurantoin, fosfomycin and gentamicin], as defined by Swedish Reference Group for Antibiotics (SRGA) breakpoints at the time of ECO . SENS 1. 
Susceptibility testing
Susceptibility testing to 12 additional antibiotics was performed on the 127 isolates, using disc diffusion on Iso-Sensitest Agar (Thermo Fisher Scientific, Basingstoke, UK) according to SRGA methodology per 2008. 17 The epidemiological cut-off values for all 24 antibiotics were calculated using the normalized interpretation method (NRI) to define the WT population for each antibiotic. 18 
Phylogenetic classification
Isolates were classified into the four main phylogenetic groups of E. coli (A, B1, B2 and D) using the triplex PCR-based method first described by Clermont et al.
19
DNA templates were extracted using the Abbott m2000sp instrument (Abbott Laboratories, IL, USA).
Primers were obtained from Thermo Fisher Scientific (Ulm, Germany). PCRs were performed using the GeneAmp PCR System 9700 (Applied Biosystems, Foster City, CA, USA) with JumpStart REDTaq polymerase (Sigma-Aldrich, St Louis, MO, USA). The original protocol was modified due to an efficiency problem with amplification and the following conditions were used for PCR: 4 min at 948C; 25 cycles of 15 s at 948C, 30 s at 608C and 45 s at 728C; and a final extension step of 5 min at 728C. E. coli ATCC 25922, used as a positive control, amplified all three products. The gene products chuA (279 bp), yjaA (211 bp) and tspE4 (152 bp) were visualized on a 1.5% Tris-acetate-EDTA agarose gel. The data obtained from the three amplifications assigned the isolate to one of four main groups (A1, B1, B2 or D). 19 
MLST
The MLST scheme for E. coli developed by Wirth et al. 4 was used (http://web.mpiib-berlin.mpg.de). DNA extraction was performed in a Qiagen BioRobot M48 device (Qiagen, Hilden, Germany) using a MagAttractA DNA Mini M48 kit (Qiagen, Hilden, Germany). DNA was amplified with a GeneAmp PCR System 9700 (Applied Biosystems). Purified PCR products were sent to Macrogen (Seoul, Korea) for DNA sequencing. Sequence alignment was performed using the BioEdit sequence Alignment Editor and allele typing online (http://web. mpiib-berlin.mpg.de).
Plasmid analysis
Plasmids were classified according to incompatibility groups using the PBRT scheme described by Caratolli et al. 9 Primers were obtained from Thermo Fisher Scientific (Ulm, Germany). PCR reactions were performed on a GeneAmp PCR System 9700 (Applied Biosystems) using JumpStart Taq polymerase (Sigma-Aldrich, St Louis, MO, USA). Amplicons were visualized on a 0.8% Tris-acetate-EDTA agarose gel. The positive controls used in the replicon typing were kindly provided by Prof Alessandra Caratolli (Istituto Superiore di Sanitá , Rome, Italy). Moreover, S1 nuclease (Promega, Madison, WI, USA)-digested linearized plasmid DNA from all isolates was examined by PFGE, as described by Naseer et al. 
Results
Susceptibility testing
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country and time period were: Greece, 18 and 12; Portugal, 19 and 10; Sweden, 13 and 17; and the UK, 12 and 11, respectively. In the sections below, the analyses are based on 80 of these isolates (the 10 first from each country and time period).
Phylogeny
The majority of the isolates belonged to phylogenetic group B2 (n¼ 53) followed by group D (n¼ 12) and group A (n¼ 15) ( Table 2 ). Group B1 was not found. No major difference in the distribution of the phylogenetic groups was observed between the four countries or between the two collection periods. The high number of isolates belonging to group B2 and D indicated the collection to be representative for uropathogenic E. coli, as similar distributions have been observed previously.
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MLST
The 80 isolates were assigned to 36 STs (13 STCs), of which 11 STs were determined for the first time in this study ( Table 2) . Twenty isolates belonged to STC73, represented by 2 isolates from Greece, 3 from Portugal, 8 from the UK and 7 from Sweden, followed by ST95 (n¼ 7) and ST420 (n¼ 6). The relationship between phylogeny and ST was good, except for STC73, STC95 and STC165, as each of these included one isolate belonging to phylogenetic group A instead of the expected B2 group (Table 2) . Also, ST420 contained two isolates belonging to phylogenetic group A and four to group D. Interestingly, we also found three isolates belonging to STs previously associated with resistance traits: STC69 (n¼ 2) and ST131 (n¼ 1).
Plasmid profiling
Two different methods were used to analyse the plasmid content: S1 nuclease plasmid PFGE and replicon typing. S1 nuclease plasmid analysis revealed that 38/80 (47.5%) isolates contained detectable plasmids. Most of these had one plasmid (n¼ 18), but some had two (n¼ 14), three (n¼ 5) or four (n¼ 1) plasmids. No definite difference in the carriage of plasmids was seen between the different STs, the countries or collection periods. A high proportion (16 out of 20 isolates) of STC73, with the exception of 4 isolates from the UK, was devoid of plasmids. The replicon typing of the isolates could only detect 17 of 18 replicons; IncL/M could not be detected, probably due to efficiency problems in the PCR step. The PBRT identified six different incompatibility groups: IncFII (n¼31); IncFIB (n¼ 26); IncI1 (n¼ 4); IncK (n¼ 1); IncY (n¼ 1); and IncB/O (n¼ 1). Portugal had the highest number of isolates with at least one replicon type (n¼ 13), followed by Greece (n¼ 9) and the UK (n¼ 9), and then Sweden (n¼ 5). The uncommon replicon types IncK, IncI1, IncY and IncB/O were identified in isolates from Sweden (n¼ 2) and Portugal (n¼5). More than one replicon type was found in 25 isolates, and in 20 of these isolates a combination of replicon types IncFIB and IncFII was detected. This combination of replicon types was common in all countries and in both collection periods. No association between replicon type and phylogroup or ST was observed ( Table 2 ). The S1 nuclease plasmid PFGE analysis did not reveal any additional plasmids, as the isolates negative in the PBRT analysis were also negative in PFGE. The isolates negative in the S1 nuclease plasmid PFGE analysis were also negative for the tested Inc groups, except for two isolates; one isolate contained an IncFII replicon and the other an IncFIB.
Discussion
The dissemination of specific E. coli lineages harbouring resistance has recently been highlighted. 4, 5, 7, 8, 21 Very little attention has been given to the E. coli populations devoid of all signs of phenotypic antibiotic resistance, designated WT. The present study adds information to this field, as several lineages (ST73, ST95 and ST420) previously associated with UTIs and antibiotic resistance 5 were shown to be the most common STs in isolates free of antibiotic resistance and collected in widely separated geographical regions of Europe. Interestingly, in a recent MLST Others  4  2  5  5  16  B2, A, D  FII, FIB, I1, Y  Total  20  20  20  20  80 STs and plasmids in E. coli devoid of phenotypic resistance 71 JAC analysis of E. coli from Swedish UTIs, ST95 was shown to belong to a group of STs underrepresented among resistant isolates (M. Sundqvist and A. Johansson, unpublished data). ST69 and ST131 have previously been associated with 'epidemics' of 'resistant' UTIs in the community. 7 In our study, we found only one isolate of each of these otherwise common STs. This indicates that there are differences in the epidemiological fitness between 'resistant' and 'susceptible' variants of these STs, and that they are more or less prone to carry resistance mechanisms.
With the PBRT method we detected 17 of 27 known replicon types, possibly indicating that the present study underestimated the prevalence of some replicons. However, the total number of plasmids accounted for by the S1 nuclease method was 65, whereas the number of rep-PCR amplicons detected was 64. Moreover, all isolates negative for the investigated replicon types were also negative in the S1 nuclease plasmid PFGE, indicating that there was a good coverage of replicon types. The method used was able to detect plasmids of 23 -600 kb, indicating that the WT isolates probably contained more plasmids than we could detect, 22 such as small plasmids, e.g. ColE1. 23 Most isolates with one or more replicons displayed a combination of IncFII and IncFIB and carried one or two plasmids. This combination of replicons has previously been reported as a multireplicon on a single plasmid, 10, 11, 13 probably due to a co-integration of two different plasmids. 24 Our analyses did not show the exact location of the IncFII and IncFIB in these isolates. Nor could we describe the localization of the replicons in the two isolates where no plasmids were found, despite their known presence. However, it has been suggested that this can be explained by the integration of plasmids in the bacterial chromosome. 1 In general, our results support the early study by Datta and Hughes 14 and the more recent study by Johnson et al. 1 Most probably, plasmids are common in uropathogenic E. coli, and IncFIB and IncFII are the most common. Some replicon types seem well adapted to E. coli 12 and their prevalence stable over time. More than half (53%) of the isolates in the present study were plasmid naive and fewer replicon types were represented than found by Johnson et al. 1 This may be due to the total lack of antibiotic resistance in the isolates investigated here in contrast to the collection described by Johnson et al. 1 Antibiotic resistance has been associated with a lower expression of virulence factors, 2 which hypothetically could affect the possibility of finding these isolates in cultures from patients with UTIs. This would result in lower fractions of WT isolates in environments with high selective pressure for antibiotic resistance genes (i.e. high antibiotic consumption). This is supported by the finding that there were fewer WT isolates in the collection from 2007-08 than in that from 1999 -2000 and from countries with high antibiotic consumption. However, over recent years, several lineages of multiresistant uropathogenic E. coli have been identified, 8 so a theoretically lower virulence due to resistance seems to be of limited epidemiological importance in everyday life. However, it may be that the presence and absence of replicons in WT isolates may be used as markers for high and low resistance rates in the community. Epidemiological studies have to be performed to verify this.
In conclusion, we show that a large proportion of E. coli selected because they were devoid of phenotypically detectable antibiotic resistance seem to be plasmid naive. Moreover, those strains harbouring plasmids exhibit a distribution of replicons almost identical to that previously reported in unselected E. coli, whereas the distribution of STs was pronouncedly different. These findings may indicate the presence of systems affecting the incorporation and/or maintenance of antibiotic resistance genes not related to plasmid restriction. In WT-prone STs this would mean a limited ability to retain multiple plasmids, leading to less recombination and less incorporation of antibiotic resistance genes. How WT bacteria benefit from these mechanisms is not yet clear, as horizontally disseminated resistance genes are not necessarily associated with a fitness cost for the bacteria. 25 In addition, the isolates in this study may not have been exposed to the combination of resistance genes and to the antibiotics needed for the incorporation and selection of the resistance genes. Antibiotics would then be a prerequisite or at least of great importance for the maintenance of plasmids with incorporated resistance genes in the bacteria. Further studies are needed to fully understand the complexity of HGT in relation to the genotype of the host and selection pressure. What actually determines the effective host range of resistance determinants is not yet understood.
